Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yvonne Hsu-Lin Luo"'
Autor:
Ahmad Ahmado, Anthony A. Vugler, Paul J. Whiting, Sakina B Gooljar, Lyndon da Cruz, Tricia Harbinson, Adnan Tufail, Conor M. Ramsden, Anna Wilbrey, Amanda J. Vernon, Mark Whitlock, Kate Fynes, Julie Kerby, Odysseas Georgiadis, Juliette Steer, Mandeep S. Sagoo, Magda Bictash, Peter J. Coffey, Amanda-Jayne F. Carr, Shazeen M Hasan, Yvonne Hsu-Lin Luo, Mike Fenster, Britta Nommiste, Graham E. Holder, Anthony G. Robson, Peter T. Loudon, Julie T. Daniels, Gang Feng
Publikováno v:
Nature Biotechnology. 36:328-337
Age-related macular degeneration (AMD) remains a major cause of blindness, with dysfunction and loss of retinal pigment epithelium (RPE) central to disease progression. We engineered an RPE patch comprising a fully differentiated, human embryonic ste
Publikováno v:
Therapeutic Advances in Ophthalmology, Vol 11 (2019)
Therapeutic Advances in Ophthalmology
Therapeutic Advances in Ophthalmology
Retinal prosthesis systems have undergone significant advances in the past quarter century, resulting in the development of several different novel surgical and engineering approaches. Encouraging results have demonstrated partial visual restoration,
Publikováno v:
Expert Review of Medical Devices. 13:673-681
Introduction: Second Sight System bionic eye implant, a commercially available visual prosthesis developed by Second Sight Medical Products, has been implanted in over 125 patients with outer retinal dystrophies such as retinitis pigmentosa. The syst
Publikováno v:
Graefe's Archive for Clinical and Experimental Ophthalmology. 253:1907-1914
The Argus® II retinal prosthesis system has entered mainstream treatment for patients blind from Retinitis Pigmentosa (RP). We set out to evaluate the use of this system by blind subjects to achieve object localisation and prehension in 3-dimensiona
Autor:
Yvonne Hsu-Lin Luo, Lyndon da Cruz
Publikováno v:
British Medical Bulletin. 109:31-44
Introduction/background The Argus® II is the first retinal prosthesis approved for the treatment of patients blind from retinitis pigmentosa (RP), receiving CE (Conformite Europeenne) marking in March 2011 and FDA approval in February 2013. Alpha-IM
Autor:
Yvonne Hsu-Lin Luo, Lyndon da Cruz
Publikováno v:
Progress in retinal and eye research. 50
The Argus(®) II Retinal Prosthesis System (Second Sight Medical Products) is the first prosthetic vision device to obtain regulatory approval in both Europe and the USA. As such it has entered the commercial market as a treatment for patients with p
Publikováno v:
Ophthalmology. 120(8)
Autor:
Yvonne Hsu-Lin Luo, Roger Wong
Publikováno v:
Ophthalmology. 112:2054